vaccines considered include vaccines to be administered locally at the portal of entry , subunit vaccines , viruses attenuated by genetic manipulation , use of viral vectors , vaccines developed by means of recombinant dna , synthetic peptides , and anti-idiotype vaccines , as well as new vaccines being developed by more conventional methods .
C0887892
subunit vaccines
C0042210
vaccines